These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 6146680)

  • 1. The pharmacokinetic profile of carbidopa in dogs.
    Obach R; Menargues A; Vallès JM
    J Pharm Pharmacol; 1984 Jun; 36(6):415-6. PubMed ID: 6146680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of carbidopa on the pharmacokinetics of intravenously administered levodopa: the mechanism of action in the treatment of parkinsonism.
    Nutt JG; Woodward WR; Anderson JL
    Ann Neurol; 1985 Nov; 18(5):537-43. PubMed ID: 4073849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic study of loprinone hydrochloride, a new cardiotonic agent, in beagle dogs.
    Uemura Y; Tanaka S; Ida S; Yuzuriha T
    J Pharm Pharmacol; 1993 Dec; 45(12):1077-81. PubMed ID: 7908977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-dependent bioavailability of prazosin in beagle dogs.
    Baughman RA; Sorgel F; Mico BA; Benet LZ
    J Cardiovasc Pharmacol; 1983; 5(4):613-7. PubMed ID: 6193359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The absolute oral bioavailability of dapsone in dogs and humans.
    Pieters FA; Zuidema J
    Int J Clin Pharmacol Ther Toxicol; 1987 Jul; 25(7):396-400. PubMed ID: 3623744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrosoluble fiber (Plantago ovata husk) and levodopa II: experimental study of the pharmacokinetic interaction in the presence of carbidopa.
    Fernandez N; Carriedo D; Sierra M; Diez MJ; Sahagun A; Calle A; Gonzalez A; Garcia JJ
    Eur Neuropsychopharmacol; 2005 Oct; 15(5):505-9. PubMed ID: 16139167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oral bioavailability of an L-5-HTP/carbidopa tablet].
    Obach R; Pruñonosa J; Vallés J; Vallés JM
    Arch Farmacol Toxicol; 1982 Dec; 8(3):179-82. PubMed ID: 6985117
    [No Abstract]   [Full Text] [Related]  

  • 8. Disposition of antimony after the administration of N-methylglucamine antimoniate to dogs.
    Valladares JE; Alberola J; Esteban M; Arboix M
    Vet Rec; 1996 Feb; 138(8):181-3. PubMed ID: 8677619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic study of salvianolic acid A in beagle dog after oral administration by a liquid chromatography-mass spectrometry method: a study on bioavailability and dose proportionality.
    Sun J; Zhang L; Song J; Tian S; Huang C; Feng Z; Lv Y; Du G
    J Ethnopharmacol; 2013 Jul; 148(2):617-23. PubMed ID: 23707334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absorption, elimination and cerebrospinal fluid concentrations of nimodipine in healthy beagle dogs receiving human intravenous and oral formulation.
    Koskimäki J; Tarkia M; Ahtola-Sätilä T; Saloranta L; Laakso A; Frantzén J
    Eur J Drug Metab Pharmacokinet; 2016 Jun; 41(3):295-300. PubMed ID: 25652785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of theophylline in beagle dogs and asthmatic patients after multiple oral doses of sustained-release theophylline tablet formulation.
    Nosaka H; Takagi K; Hasegawa T; Ogura Y; Mizukami Y; Satake T
    Int J Clin Pharmacol Ther Toxicol; 1986 Oct; 24(10):528-35. PubMed ID: 3781672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on pharmacokinetics and absolute bioavailability of sinomenine in beagle dogs].
    Chen W; Zhou Y; Kang J; Li Q; Feng X
    Zhongguo Zhong Yao Za Zhi; 2009 Feb; 34(4):468-71. PubMed ID: 19459314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of carbidopa and entacapone pretreatment on the L-dopa pharmacokinetics and metabolism in blood plasma and skeletal muscle in beagle dog: an in vivo microdialysis study.
    Deleu D; Sarre S; Ebinger G; Michotte Y
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1323-31. PubMed ID: 7791104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
    Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic aspects of isosorbide-5-mononitrate in dogs.
    Sponer G; Kühnle HF; Strein K; Bartsch W; Endele R; Dietmann K
    J Pharmacol Exp Ther; 1984 Jan; 228(1):235-9. PubMed ID: 6694105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clearance of rFVIIa and NN1731 after intravenous administration to Beagle dogs.
    Agersø H; Kristensen NR; Østergaard H; Karpf DM; Hermit MB; Pelzer H; Petersen LC; Ezban M
    Eur J Pharm Sci; 2011 Apr; 42(5):578-83. PubMed ID: 21382491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of triflusal and its main metabolite in rats and dogs.
    Ramis J; Mis R; Forn J
    Eur J Drug Metab Pharmacokinet; 1991; 16(4):261-8. PubMed ID: 1823869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral pharmacokinetic handling and metabolism of L-dopa in the rat: the effect of route of administration and carbidopa pretreatment.
    Rose S; Jenner P; Marsden CD
    J Pharm Pharmacol; 1991 May; 43(5):325-30. PubMed ID: 1680174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic profile of idazoxan in the beagle dog.
    Vallès J; Pruñonosa J; Menargues A; Nomen M; Obach R
    J Pharm Pharmacol; 1989 Jun; 41(6):384-7. PubMed ID: 2570833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of silymarin proliposome: a new way to increase oral bioavailability of silymarin in beagle dogs.
    Yan-yu X; Yun-mei S; Zhi-peng C; Qi-neng P
    Int J Pharm; 2006 Aug; 319(1-2):162-8. PubMed ID: 16687221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.